Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Humanwell Healthcare (Group) Co's Days Payable or its related term are showing as below:
SHSE:600079'
s Days Payable Range Over the Past 10 Years
Min: 78.85 Med: 90.12 Max: 116.85
Current: 88.13
During the past 13 years, Humanwell Healthcare (Group) Co's highest Days Payable was 116.85. The lowest was 78.85. And the median was 90.12.
SHSE:600079's Days Payable is ranked worse than 51.67% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:600079: 88.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humanwell Healthcare (Group) Co Days Payable Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humanwell Healthcare (Group) Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Humanwell Healthcare (Group) Co's Days Payable falls into.
Humanwell Healthcare (Group) Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Humanwell Healthcare (Group) Co (SHSE:600079) has a Days Payable of 88.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Humanwell Healthcare (Group) Co and its competitors. This is near median its historical median of 90.12. Over the past decade, Humanwell Healthcare (Group) Co's Days Payable has ranged from 78.85 to 116.85. According to the industry distribution chart, Humanwell Healthcare (Group) Co ranks #479 out of 927 companies in the Drug Manufacturers industry, placing it in the top 51.7%.
Is Humanwell Healthcare (Group) Co's Days Payable too high?
Humanwell Healthcare (Group) Co's current Days Payable of 88.79 is near median its 10-year median of 90.12. Over the past 10 years, this metric has ranged from a low of 78.85 to a high of 116.85. The Drug Manufacturers industry median Days Payable is 90.38. Humanwell Healthcare (Group) Co's value of 88.79 is 1.8% below this industry median. Based on the distribution chart, Humanwell Healthcare (Group) Co ranks #479 out of 927 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Humanwell Healthcare (Group) Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Humanwell Healthcare (Group) Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Humanwell Healthcare (Group) Co ranks #479 out of 927 companies for Days Payable. This places Humanwell Healthcare (Group) Co in the lower half of its industry. The industry median Days Payable is 90.38. Humanwell Healthcare (Group) Co's value of 88.79 is 1.8% below this benchmark. Historically, Humanwell Healthcare (Group) Co's own Days Payable has ranged from 78.85 to 116.85 over the past decade. While the company's 10-year median is 90.12 vs. the industry median of 90.38, Humanwell Healthcare (Group) Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humanwell Healthcare (Group) Co's current Days Payable of 88.79 is 1.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Humanwell Healthcare (Group) Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humanwell Healthcare (Group) Co's current Days Payable is 88.79, which is near median its own 10-year median of 90.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humanwell Healthcare (Group) Co stock overvalued right now?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co (SHSE:600079) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥21.63, compared to a current price of ¥17.41 — trading 19.5% below its estimated fair value. The current Days Payable is 88.79, which is near median its 10-year median of 90.12 and 1.8% below the Drug Manufacturers industry median of 90.38. Humanwell Healthcare (Group) Co's overall GF Score™ is 61/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Humanwell Healthcare (Group) Co (SHSE:600079), the current Days Payable is 88.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humanwell Healthcare (Group) Co (SHSE:600079) Overvalued in 2026?
Based on GuruFocus' analysis, Humanwell Healthcare (Group) Co stock appears to be undervalued.
The current stock price of ¥17.41 is trading 19.5% below its estimated GF Value™ of ¥21.63.
GuruFocus considers Humanwell Healthcare (Group) Co to be Modestly Undervalued.
Key valuation signals for SHSE:600079:
Days Payable: 88.79 (near median its 10-year median of 90.12)
GF Value™: ¥21.63 vs. price of ¥17.41 (19.5% below fair value)
Industry Position: 1.8% below the Drug Manufacturers median (#479 of 927)
No single metric tells the full story. See the SHSE:600079 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humanwell Healthcare (Group) Co Business Description
Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. It provides medicinal products including fertility-regulating drugs, Uyghur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.
61GF Score
Get the complete analysis for SHSE:600079
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600079 has been successfully added to your 
